(Total Views: 483)
Posted On: 04/27/2025 10:38:31 AM
Post# of 151986
May 15th:
1. We own all trial data.
2. Officially elevated above the optics of being another Hiv combo company.
3. Only company to validate a large molecule / CCR5 / CCL5 in 3rd party papers & trials -- years of each.
4. Validates Leronlimab's lack of SAE's as related to future 1600 patient manuscript.
5. Validates our iP --- that value alone is staggering upon MOA showing the paradim shift potential.
1. We own all trial data.
2. Officially elevated above the optics of being another Hiv combo company.
3. Only company to validate a large molecule / CCR5 / CCL5 in 3rd party papers & trials -- years of each.
4. Validates Leronlimab's lack of SAE's as related to future 1600 patient manuscript.
5. Validates our iP --- that value alone is staggering upon MOA showing the paradim shift potential.
(6)
(1)Scroll down for more posts ▼
